Reuters logo
BRIEF-Novartis says analyses reinforce potential of Ultibro Breezhaler for COPD patients
2017年5月23日 / 凌晨5点22分 / 4 个月前

BRIEF-Novartis says analyses reinforce potential of Ultibro Breezhaler for COPD patients

May 23 (Reuters) - Novartis Ag

* Novartis’ new analyses reinforce the potential of Ultibro Breezhaler for COPD patients historically treated with steroids Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below